The PD-L1/22C3 assay for primary lung cancer is feasible for daily clinical practice irrespective of the diagnostic procedure, SUGANUMA Hiromitsu;KUSUMOTO Sojiro;MANABE Ryo;KISHINO Yasunari;ENDO Tetsuya;ANDO Koichi;ISHIDA Hiroo;HORIIKE Atsushi;TANAKA Akihiko;TAKEI Hidefumi;YAMOCHI Toshiko;TSUNODA Takuya;SAGARA Hironori, Showa Univ J Med Sci, 34(2):64 - 77, 2022年06月, 原著, 査読あり, DOI:https://doi.org/10.15369/sujms.34.64